Thermo Fisher Scientific R&D decreased by 1.8% to $336.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 1.8%, from $342.00M to $336.00M. Over 3 years (FY 2021 to FY 2024), R&D shows relatively stable performance with a -0.4% CAGR.
Analysis
StatementIncome Statement
SectionOperating Expenses
CategoryGrowth
SignalContext dependent
VolatilityModerate
First reportedQ1 2013
Last reportedQ1 2026May 1, 2026
How to read this metric
Higher spending signals a commitment to innovation and future product launches, whereas significant cuts may indicate a shift toward short-term profitability.
Detailed definition
Research and development expenses represent the costs incurred to discover new products, improve existing technologies,...
Peer comparison
Highly comparable across pharmaceutical and medical device peers, where R&D intensity is a key metric for long-term valuation.
Metric ID:
research_and_developmentHistorical Data
17 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $343.00M | $351.00M | $392.00M | $364.00M | $365.00M | $351.00M | $391.00M | $346.00M | $345.00M | $319.00M | $327.00M | $331.00M | $339.00M | $346.00M | $374.00M | $342.00M | $336.00M |
| QoQ Change | — | +2.3% | +11.7% | -7.1% | +0.3% | -3.8% | +11.4% | -11.5% | -0.3% | -7.5% | +2.5% | +1.2% | +2.4% | +2.1% | +8.1% | -8.6% | -1.8% |
| YoY Change | — | — | — | — | +6.4% | +0.0% | -0.3% | -4.9% | -5.5% | -9.1% | -16.4% | -4.3% | -1.7% | +8.5% | +14.4% | +3.3% | -1.8% |
Range$319.00M – $392.00M
CAGR-0.5%
Avg YoY Growth-0.9%
Median YoY Growth-1.7%
Current Streak2 quarters decline
Business Segments
| Segment | Q3 '25 | Q1 '26 |
|---|---|---|
| Analytical Instruments | $144.00M | $139.00M |
| Life Sciences Solutions | $136.00M | $131.00M |
| Specialty Diagnostics | $42.00M | $44.00M |
| Laboratory Products and Biopharma Services | $14.00M | $15.00M |
| Total | — | $336.00M |
R&D at Other Companies
Frequently Asked Questions
- What is Thermo Fisher Scientific's r&d?
- Thermo Fisher Scientific (TMO) reported r&d of $336.00M in Q1 2026.
- How has Thermo Fisher Scientific's r&d changed year-over-year?
- Thermo Fisher Scientific's r&d decreased by 1.8% year-over-year, from $342.00M to $336.00M.
- What is the long-term trend for Thermo Fisher Scientific's r&d?
- Over 3 years (2021 to 2024), Thermo Fisher Scientific's r&d has grown at a -0.4% compound annual growth rate (CAGR), from $1.41B to $1.39B.
- What does r&d mean?
- The money spent on creating new products or improving existing ones to drive future growth.